Dr. David Shindler

Senior Associate, The Impact Group

Dr. David Shindler

Building on his senior executive experience in business development and strategic technology management, Dr. Shindler is an innovation consultant, working with Canadian and international clients. He specializes in ventures based on advanced technologies in the biomedical, environmental and device areas. From 2008-2011, he was Executive Director of Springboard Atlantic - a regional commercialization network comprising 19 universities and colleges. Before that he served as Executive Director of BioDiscovery Toronto. Earlier roles include being the founding President and CEO of Milestone Medica Corporation; Senior Executive and Commercial Director of the Canadian Genetic Diseases Network NCE; and manager of Canada's National Biotechnology Advisory Committee. Dr. Shindler is appointed to a number of boards and committees, including serving as a Director of Health Technology Exchange; as Chair of the Board of MABNet, an NSERC strategic network; and as a member of the Research Management Committee of the Allergen NCE. His Ph.D. is from the University of Ottawa with specialization in microbiology and biochemistry.